Natural polyprenylated benzophenones inhibiting cysteine and serine proteases
dc.contributor.author | Martins, Felipe T. | |
dc.contributor.author | Assis, Diego M. | |
dc.contributor.author | Santos, Marcelo H. dos | |
dc.contributor.author | Camps, I. | |
dc.contributor.author | Veloso, Marcia P. | |
dc.contributor.author | Juliano, Maria A. [UNIFESP] | |
dc.contributor.author | Alves, Lira C. | |
dc.contributor.author | Doriguetto, Antonio C. | |
dc.contributor.institution | Univ Fed Alfenas | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.date.accessioned | 2016-01-24T13:52:19Z | |
dc.date.available | 2016-01-24T13:52:19Z | |
dc.date.issued | 2009-03-01 | |
dc.description.abstract | We have investigated the in vitro inhibition of papain, trypsin, and cathepsins B and G by five benzophenone-type compounds, three natural ones isolated from Garcinia brasiliensis and two synthetic derivatives. the activities of pentaprenylated trihydroxy-substituted benzophenone guttiferone A (1) on all assayed enzymes were approximately 2-69 folds higher than that manifested by mono-hydroxylated tetraprenylated and triprenylated compounds epiclusianone (2) and garciniaphenone (3), respectively, the other natural benzophenones that also inhibited significantly the four enzymes. Differently, the synthetic derivatives 2,2',4-trihydroxybenzophenone (4) and diphenylmethanone (5) have inhibited weakly the studied proteases. Furthermore, compound 1 has bonded preferentially to cathepsin G, once its IC(50) value (2.7 +/- 0.1 mu M) on such peptidase is quite similar to that of the classical inhibitor of serine proteases, chymostatin (2.1 +/- 0.1 mu M). Interesting structure-activity relationships (SARs) were confirmed by flexible docking simulations, likewise the potential usefulness of natural compound 1 as antitumoral drug is strengthened by our results concerning the antiproteolytic activity. (C) 2008 Elsevier Masson SAS. All rights reserved. | en |
dc.description.affiliation | Univ Fed Alfenas, Dept Exact Sci, BR-37130000 Alfenas, MG, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Biophys, BR-04044020 São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Biophys, BR-04044020 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) | |
dc.description.sponsorship | FINEP (Financiadora de Estudos e Projetos) | |
dc.description.sponsorshipID | FAPEMIG: EDT-3310/06 | |
dc.description.sponsorshipID | FINEP (Financiadora de Estudos e Projetos): 1110/06 | |
dc.format.extent | 1230-1239 | |
dc.identifier | http://dx.doi.org/10.1016/j.ejmech.2008.09.018 | |
dc.identifier.citation | European Journal of Medicinal Chemistry. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 44, n. 3, p. 1230-1239, 2009. | |
dc.identifier.doi | 10.1016/j.ejmech.2008.09.018 | |
dc.identifier.issn | 0223-5234 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/31355 | |
dc.identifier.wos | WOS:000264558600035 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | European Journal of Medicinal Chemistry | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | Benzophenones | en |
dc.subject | Proteases | en |
dc.subject | Guttiferone A | en |
dc.subject | Cathepsin G | en |
dc.subject | SAR | en |
dc.subject | Flexible docking | en |
dc.title | Natural polyprenylated benzophenones inhibiting cysteine and serine proteases | en |
dc.type | info:eu-repo/semantics/article |